Mangoceuticals (MGRX) Competitors $2.81 -1.94 (-40.84%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$2.81 0.00 (0.00%) As of 03/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX vs. ENZ, CCM, OPGN, MRAI, BRTX, KDLY, SSY, OTRK, BGLC, and ATIPShould you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Enzo Biochem (ENZ), Concord Medical Services (CCM), OpGen (OPGN), Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), SunLink Health Systems (SSY), Ontrak (OTRK), BioNexus Gene Lab (BGLC), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry. Mangoceuticals vs. Enzo Biochem Concord Medical Services OpGen Marpai BioRestorative Therapies Kindly MD SunLink Health Systems Ontrak BioNexus Gene Lab ATI Physical Therapy Enzo Biochem (NYSE:ENZ) and Mangoceuticals (NASDAQ:MGRX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, community ranking, institutional ownership, valuation and dividends. Do insiders and institutionals have more ownership in ENZ or MGRX? 36.9% of Enzo Biochem shares are owned by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are owned by institutional investors. 11.4% of Enzo Biochem shares are owned by insiders. Comparatively, 16.0% of Mangoceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is ENZ or MGRX more profitable? Enzo Biochem has a net margin of -75.34% compared to Mangoceuticals' net margin of -1,237.00%. Enzo Biochem's return on equity of -7.96% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Enzo Biochem-75.34% -7.96% -5.49% Mangoceuticals -1,237.00%-138.00%-118.88% Does the MarketBeat Community believe in ENZ or MGRX? Enzo Biochem received 212 more outperform votes than Mangoceuticals when rated by MarketBeat users. CompanyUnderperformOutperformEnzo BiochemOutperform Votes21253.13% Underperform Votes18746.87% MangoceuticalsN/AN/A Which has more volatility and risk, ENZ or MGRX? Enzo Biochem has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 1.51, meaning that its stock price is 51% more volatile than the S&P 500. Which has higher valuation and earnings, ENZ or MGRX? Mangoceuticals has lower revenue, but higher earnings than Enzo Biochem. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnzo Biochem$29.09M0.82-$26.08MN/AN/AMangoceuticals$755K9.26-$9.21M-$4.85-0.58 Does the media refer more to ENZ or MGRX? In the previous week, Mangoceuticals had 5 more articles in the media than Enzo Biochem. MarketBeat recorded 7 mentions for Mangoceuticals and 2 mentions for Enzo Biochem. Mangoceuticals' average media sentiment score of 0.18 beat Enzo Biochem's score of 0.00 indicating that Mangoceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enzo Biochem 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Mangoceuticals 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMangoceuticals beats Enzo Biochem on 7 of the 12 factors compared between the two stocks. Remove Ads Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRX vs. The Competition Export to ExcelMetricMangoceuticalshealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.99M$2.01B$5.68B$8.30BDividend YieldN/A7.11%4.55%4.02%P/E Ratio-0.4915.7324.5519.25Price / Sales9.263.68395.7294.10Price / CashN/A9.3238.1634.64Price / Book5.204.357.064.46Net Income-$9.21M$87.49M$3.19B$247.07M7 Day Performance-34.19%0.44%0.18%1.77%1 Month Performance-36.57%11.48%5.54%-3.31%1 Year Performance-93.91%-23.55%14.22%5.26% Mangoceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRXMangoceuticals1.1032 of 5 stars$2.81-40.8%N/A-93.4%$6.99M$755,000.00-0.493Earnings ReportPositive NewsTrading HaltedHigh Trading VolumeENZEnzo Biochem1.5498 of 5 stars$0.47-4.7%N/A-63.8%$24.76M$30.31M0.00520Analyst ForecastNews CoverageCCMConcord Medical Services0.3913 of 5 stars$4.53+2.1%N/A-1.7%$19.69M$471.70M0.00970Analyst ForecastNews CoverageGap UpOPGNOpGenN/A$1.75+52.2%N/A-43.2%$14.62M$2.67M0.00100Analyst ForecastNews CoverageHigh Trading VolumeMRAIMarpai1.4151 of 5 stars$0.95+4.4%$6.00+531.6%-46.1%$13.76M$34.87M-0.36150Upcoming EarningsNews CoverageGap UpBRTXBioRestorative Therapies2.6269 of 5 stars$1.67-5.6%$18.00+977.8%+37.1%$11.56M$377,000.00-1.097News CoverageKDLYKindly MDN/A$1.57+4.7%N/AN/A$9.38M$2.88M0.00N/ANews CoveragePositive NewsGap DownSSYSunLink Health SystemsN/A$0.99-1.1%N/A+37.8%$6.94M$31.23M7.041,376Gap DownOTRKOntrak1.971 of 5 stars$1.47+2.1%$45.00+2,961.2%-69.2%$6.20M$11.24M-0.14250BGLCBioNexus Gene Lab0.9687 of 5 stars$0.31-11.7%N/A-60.7%$5.55M$9.26M0.0030Positive NewsATIPATI Physical TherapyN/A$1.25+3.3%N/A-80.5%$5.51M$741.86M-0.075,600Gap Up Remove Ads Related Companies and Tools Related Companies ENZ Alternatives CCM Alternatives OPGN Alternatives MRAI Alternatives BRTX Alternatives KDLY Alternatives SSY Alternatives OTRK Alternatives BGLC Alternatives ATIP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRX) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
